Phathom Pharmaceuticals, Inc. (PHAT)
11.87
-1.18
(-9.04%)
USD |
NASDAQ |
May 15, 16:00
11.87
0.00 (0.00%)
After-Hours: 20:00
Phathom Pharmaceuticals EPS Diluted (Quarterly) : -0.3701 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 1.276 |
| Ligand Pharmaceuticals, Inc. | -0.6712 |
| Axsome Therapeutics, Inc. | -1.261 |
| Corcept Therapeutics, Inc. | -0.2988 |
| Assertio Holdings, Inc. | -2.931 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -30.37M |
| Revenue (Quarterly) | 58.30M |
| Total Expenses (Quarterly) | 88.67M |
| Enterprise Value | 1.313B |
| Gross Profit Margin (Quarterly) | 79.42% |
| Profit Margin (Quarterly) | -52.09% |
| Earnings Yield | -17.79% |
| Normalized Earnings Yield | -17.79 |